TargetMol

RA 642

Product Code:
 
TAR-T26027
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26027-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26027-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26027-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
RA 642 is used as a PDE-inhibitor.
CAS:
54093-30-0
Formula:
C24H44N8O4
Molecular Weight:
508.668
Purity:
0.98
SMILES:
CCN(CC)c1nc(nc2c(nc(nc12)N(CCO)CCOC)N(CC)CC)N(CCO)CCOC

References

1. Jonkman FA, Thoolen MJ, Wilffert B, de Jonge A, Timmermans PB, Van Zwieten PA. Effect of salbutamol and the PDE-inhibitor RA 642 on the clonidine withdrawal syndrome in rats. J Auton Pharmacol. 1984 Sep;4(3):199-206. PubMed PMID: 6092386. 2. de la Cruz JP, Moreno A, M?rida F, Garc?a-Campos J, S?nchez de la Cuesta F. The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats. Pharmacol Toxicol. 1994 Nov;75(5):250-4. PubMed PMID: 7870694. 3. De La Cruz JP, Villalobos MA, Carrasco T, Smith-Agreda JM, S?nchez de la Cuesta F. The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion. Brain Res. 1992 Dec 4;597(2):250-6. PubMed PMID: 1472997. 4. Hock CE, Lefer DJ, Lefer AM. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642. Methods Find Exp Clin Pharmacol. 1986 May;8(5):265-9. PubMed PMID: 3724301.